Glycerin
- Generic Name
- Glycerin
- Brand Names
- Clear Eyes Cooling Comfort, Clear Eyes Redness Relief Reformulated Nov 2011, Fleet Mineral Oil, Genteal Tears, Glycerolyte 57, Pedia-lax Liquid, Preparation H Cream, Procalamine 3, Refresh Optive Advanced, Refresh Optive Extended Therapy, Synovisol, Tears Lubricant
- Drug Type
- Small Molecule
- Chemical Formula
- C3H8O3
- CAS Number
- 56-81-5
- Unique Ingredient Identifier
- PDC6A3C0OX
- Background
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
- Indication
It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
- Associated Conditions
- Cold Sore, Constipation, Dry Mouth, Dry Skin, Dry throat, Edema of the cerebrum, Increase in Intracranial Pressure (ICP), Occasional Constipation, Ocular Discomfort, Ocular Hypertension, Ocular Irritation, Skin Infections, Sore Throat, Mouth soreness, Sensation of burning in the eyes
- Associated Therapies
- Bowel preparation therapy, Topical Antisepsis, Skin protection
Effectiveness of Topical Glycerine Sulphate Paste, Hirudoid Cream and Nil Application on Superficial Phlebitis
Not Applicable
Completed
- Conditions
- Infection
- Interventions
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2010-10-21
- Lead Sponsor
- Tan Tock Seng Hospital
- Target Recruit Count
- 147
- Registration Number
- NCT01226069
- Locations
- 🇸🇬
Tan Tock Seng Hospital, Singapore, Singapore
Dermacyd in Odor Reducing.
Phase 3
Completed
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID (Dermacid)
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2011-01-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 230
- Registration Number
- NCT01158365
- Locations
- 🇧🇷
Sanofi-Aventis Investigational Site Number 076-001, Osasco, Brazil
Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional
Phase 3
Completed
- Conditions
- Hygiene
- Interventions
- Drug: Dermacid Silver (Lactic acid)
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 70
- Registration Number
- NCT01126606
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
Not Applicable
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2015-08-17
- Lead Sponsor
- Allergan
- Target Recruit Count
- 288
- Registration Number
- NCT01010282
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
Not Applicable
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2015-08-26
- Lead Sponsor
- Allergan
- Target Recruit Count
- 47
- Registration Number
- NCT00932477
Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy
Not Applicable
Completed
- Conditions
- Hypertensive Anal Canal
- Interventions
- Procedure: lateral internal sphincterotomy (LIS)Drug: botulinum toxin injection (BTX A)
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2009-06-25
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 63
- Registration Number
- NCT00927849
- Locations
- 🇪🇬
Ayman Elnakeeb, Mansoura, Egypt
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Not Applicable
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: 20% lipid infusion
- First Posted Date
- 2008-11-06
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 33
- Registration Number
- NCT00786487
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation
Phase 4
- Conditions
- Dermatitis, ContactDermatitis, Occupational
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Odense University Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT00779792
- Locations
- 🇩🇰
Department of Dermatology, Odense University Hospital, Odense, Denmark
Tear Film Break-up Time After Instillation of Artificial Tears
Not Applicable
Completed
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2012-10-26
- Lead Sponsor
- Calm Water Therapeutics LLC
- Target Recruit Count
- 16
- Registration Number
- NCT00681265
- Locations
- 🇺🇸
University of Rochester Eye Institute, Rochester, New York, United States
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Phase 3
Completed
- Conditions
- Bacterial Meningitis
- Interventions
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Kamuzu University of Health Sciences
- Target Recruit Count
- 466
- Registration Number
- NCT00619203
- Locations
- 🇲🇼
College of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath